A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China.
Lin W, Wang X, Zhang J, Wen C, Kang W, Mao L, Yang J, Dou Y, Shi L, Dang B, Lan Y, Li H, Li Y, Chen X, He H, Xu M, He Y, Hu F, Lu R, Cai W, Li L.
Lin W, et al. Among authors: li y, li h, li l.
Lancet Reg Health West Pac. 2023 Mar 25;36:100749. doi: 10.1016/j.lanwpc.2023.100749. eCollection 2023 Jul.
Lancet Reg Health West Pac. 2023.
PMID: 37547041
Free PMC article.